Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · IEX Real-Time Price · USD
24.70
-0.38 (-1.54%)
Jul 22, 2024, 11:45 AM EDT - Market open
Intellia Therapeutics Analyst Ratings
Total Analysts
15
Consensus Rating
Buy
Price Target
$66.93
Upside
+171.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $73 | Strong Buy | Maintains | $73 | +195.61% | Jun 27, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +163.21% | Jun 24, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $120 | Strong Buy | Maintains | $120 | +385.93% | Jun 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +163.21% | Jun 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +163.21% | Jun 4, 2024 |
| Citigroup | Citigroup | Hold Maintains $31 → $29 | Hold | Maintains | $31 → $29 | +17.43% | May 10, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $62 → $70 | Buy | Maintains | $62 → $70 | +183.46% | May 10, 2024 |
| Wedbush | Wedbush | Hold Reiterates $29 | Hold | Reiterates | $29 | +17.43% | Apr 23, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $32 | Strong Buy → Hold | Downgrades | $32 | +29.58% | Feb 23, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $72 → $73 | Strong Buy | Maintains | $72 → $73 | +195.61% | Feb 23, 2024 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 15, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $80 → $70 | Buy | Maintains | $80 → $70 | +183.46% | Nov 13, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $90 → $85 | Buy | Maintains | $90 → $85 | +244.20% | Nov 13, 2023 |
| BMO Capital | BMO Capital | Buy Maintains $64 → $62 | Buy | Maintains | $64 → $62 | +151.06% | Nov 10, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $80 → $70 | Buy | Maintains | $80 → $70 | +183.46% | Nov 10, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $157 → $136 | Strong Buy | Maintains | $157 → $136 | +450.72% | Nov 10, 2023 |
| Raymond James | Raymond James | Buy Maintains $78 → $57 | Buy | Maintains | $78 → $57 | +130.82% | Nov 10, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +163.21% | Sep 13, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +163.21% | Aug 29, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +163.21% | Aug 9, 2023 |
| Barclays | Barclays | Buy Maintains $86 → $90 | Buy | Maintains | $86 → $90 | +264.45% | Aug 7, 2023 |